Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
This Month's Featured News Rocket Lab Gets a Big Upgrade: Will Upside Follow?Authored by Ryan Hasson. Publication Date: 1/20/2026. 
At a Glance - Morgan Stanley just turned bullish on Rocket Lab, upgrading the stock to Overweight from Equalweight and raising its price target to a Street-high $105.
- Neutron and Electron remain key catalysts, with a potential Neutron debut in early 2026 and rising launch cadence supporting the long-term growth narrative amid strong space and defense tailwinds.
- Short-term risk is elevated, as RKLB is overbought after a parabolic run, making pullbacks and consolidation more attractive entry points than chasing strength.
Shares of Rocket Lab (NASDAQ: RKLB) received another major vote of confidence this month after Morgan Stanley significantly upgraded its rating and price target on the stock. On Jan. 16, 2026, the firm raised its rating from Equal Weight to Overweight and lifted its price target from $67 to a Street-high $105. The timing is notable: Rocket Lab is already trading at all-time highs, closing the Jan. 16 session at $96.30. That move pushed the stock's year-to-date gain to 38%, while its one-year performance now stands at an eye-catching 287%. With shares deep into a parabolic run, Morgan Stanley's bullish call raises an important question for investors: Is there still near-term upside, or has the market already priced it in? Morgan Stanley Turns Bullish on Space and Rocket Lab A major force in the crypto world is quietly becoming one of gold's most aggressive buyers — and most investors have no idea it's happening.
A longtime gold analyst says profits from a leading stablecoin operation are being funneled into physical gold at a scale that could materially impact supply and demand. After a recent meeting with insiders, he began outlining what this trend could mean for gold prices and a small group of companies positioned to benefit. Read the full gold briefing here Morgan Stanley analyst Kristine Liwag framed the upgrade within a broader, optimistic outlook for the space-technology sector in 2026. The firm has adopted what it calls an "Attractive" view on space tech, arguing that many of the drivers behind last year's outperformance remain firmly in place. It's a similar view to what MarketBeat previously noted for Rocket Lab and the overall sector. "2025 was a banner year for the space industry on several fronts," Liwag wrote, adding that higher launch cadences, new product introductions, and policy support should fuel 2026. For Rocket Lab specifically, Morgan Stanley highlighted two key catalysts: expectations for the company's first Neutron rocket launch in early 2026, and continued increases in launch cadence for its Electron rocket. Neutron, in particular, represents a step-change opportunity for Rocket Lab — it opens the door to larger payloads, higher-margin missions, and deeper exposure to defense and national-security contracts. Why the Bull Case Still Has Legs Despite the stock's sharp run, Rocket Lab continues to benefit from multiple structural tailwinds. The company recently secured an $816 million multi-year contract, reinforcing its growing role in government and defense-related space infrastructure. Meanwhile, global investment in space and defense remains elevated, driven by geopolitical tensions and national-security priorities that are accelerating government spending. There's also a broader sentiment tailwind at work. Speculation around a potential SpaceX IPO has put a spotlight on the broader space ecosystem, often lifting publicly traded peers like Rocket Lab along with it. That said, Wall Street remains divided. RKLB currently carries a Moderate Buy consensus based on 16 analyst opinions, with an average price target near $64 — well below current levels. A successful Neutron debut, however, could force analysts to materially reassess revenue potential and valuation, potentially triggering a broader re-rating. Is RKLB a Buy at These Levels? While the long-term story remains compelling, the near-term technical picture suggests caution. Rocket Lab is firmly in overbought territory, with momentum indicators such as the RSI stretched following the stock's rapid ascent. For investors who bought shares at lower levels, the trends support continuing to hold. For new investors, patience may be warranted. A pullback into key short- and mid-term moving averages, followed by consolidation and base-building, would offer a more attractive risk-reward setup. In short, Morgan Stanley's upgrade reinforces Rocket Lab's long-term potential, but after a near-vertical rally the next high-probability entry may come on a pause — not a chase.
| 
No comments:
Post a Comment
Keep a civil tongue.